Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;92(4):275-282.
doi: 10.1016/j.biopsych.2021.12.003. Epub 2021 Dec 13.

Persistent Childhood and Adolescent Anxiety and Risk for Psychosis: A Longitudinal Birth Cohort Study

Affiliations

Persistent Childhood and Adolescent Anxiety and Risk for Psychosis: A Longitudinal Birth Cohort Study

Isabel Morales-Muñoz et al. Biol Psychiatry. .

Abstract

Background: Persistent anxiety in childhood and adolescence could represent a novel treatment target for psychosis, potentially targeting activation of stress pathways and secondary nonresolving inflammatory response. Here, we examined the association between persistent anxiety through childhood and adolescence with individuals with psychotic experiences (PEs) or who met criteria for psychotic disorder (PD) at age 24 years. We also investigated whether C-reactive protein mediated any association.

Methods: Data from the Avon Longitudinal Study of Parents and Children (ALSPAC) were available in 8242 children at age 8 years, 7658 at age 10 years, 6906 at age 13 years, and 3889 at age 24 years. The Development and Well-Being Assessment was administered to capture child and adolescent anxiety. We created a composite score of generalized anxiety at ages 8, 10, and 13. PEs and PD were assessed at age 24, derived from the Psychosis-like Symptoms Interview. The mean of C-reactive protein at ages 9 and 15 years was used as a mediator.

Results: Individuals with persistent high levels of anxiety were more likely to develop PEs (odds ratio 2.02, 95% CI 1.26-3.23, p = .003) and PD at age 24 (odds ratio 4.23, 95% CI 2.27-7.88, p < .001). The mean of C-reactive protein at ages 9 and 15 mediated the associations of persistent anxiety with PEs (bias-corrected estimate -0.001, p = .013) and PD (bias-corrected estimate 0.001, p = .003).

Conclusions: Persistent high levels of anxiety through childhood and adolescence could be a risk factor for psychosis. Persistent anxiety is potentially related to subsequent psychosis via activation of stress hormones and nonresolving inflammation. These results contribute to the potential for preventive interventions in psychosis, with the novel target of early anxiety.

Keywords: ALSPAC; Anxiety; C-reactive protein; Inflammation; Psychosis; Trajectories.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Growth trajectories of anxiety across childhood to adolescence. The latent class growth analyses detected a best model fit for 3 classes. Class 1 (blue line on the bottom) represents individuals with persistent low levels of anxiety across time points. Class 2 (red line in the middle) represents individuals with persistent intermediate levels of anxiety. Class 3 (green line on the top) represents individuals with persistent high levels of anxiety across time points, which was the main focus of this study.
Figure 2
Figure 2
Path diagram showing the main direct associations. Only the direct associations of the independent variable, mediating factor, and dependent variable are shown. Persistent high levels of anxiety represent the independent variable; the mean of C-reactive protein (CRP) levels at ages 9 and 15 represent the mediating factor; and psychotic experiences (A) and meeting criteria for psychotic disorder (B) at age 24 represent the outcomes. The covariates also included in this path analysis were sex, family adversity, birth weight, and cannabis use at age 15. Significant pathways are indicated by solid arrows.

Comment in

References

    1. Radua J., Ramella-Cravaro V., Ioannidis J.P.A., Reichenberg A., Phiphopthatsanee N., Amir T., et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17:49–66. - PMC - PubMed
    1. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586. - PubMed
    1. Kirkbride J.B., Errazuriz A., Croudace T.J., Morgan C., Jackson D., Boydell J., et al. Incidence of schizophrenia and other psychoses in England, 1950-2009: A systematic review and meta-analyses. PLoS One. 2012;7 - PMC - PubMed
    1. Cloutier M., Aigbogun M.S., Guerin A., Nitulescu R., Ramanakumar A.V., Kamat S.A., et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77:764–771. - PubMed
    1. Fusar-Poli P., Rutigliano G., Stahl D., Davies C., Bonoldi I., Reilly T., et al. Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis. JAMA Psychiatry. 2017;74:493–500. - PMC - PubMed

Publication types

Substances